Company introduction

Shanghai King-cell Biotechnology Co. Ltd. was established in Shanghai Jinshan Industrial Zone on April 19, 2017. As a bio pharmaceutical enterprise, King-cell is committed to innovation and safe vaccine development and production. It was formerly known as Beijing Cell-fusion Biotechnology Co. Ltd. located in zhongguancun Beijing, after more than 6 years research, the company obtained the clinical approval of human rabies vaccine (chicken embryo fibroblast); the new-genotype MMR vaccine, inactivated rotavirus vaccine and respiratory syncytial virus vaccine are under research.King-cell covers an area of 80 acres in Jinshan Industrial Zone, in which …...

VIEW ALL >>